The tumour microenvironment and immune milieu of cholangiocarcinoma.


Journal

Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857

Informations de publication

Date de publication:
05 2019
Historique:
received: 11 01 2019
revised: 25 02 2019
accepted: 27 02 2019
pubmed: 26 3 2019
medline: 16 1 2020
entrez: 26 3 2019
Statut: ppublish

Résumé

Tumour microenvironment is a complex, multicellular functional compartment that, particularly when assembled as an abundant desmoplastic reaction, may profoundly affect the proliferative and invasive abilities of epithelial cancer cells. Tumour microenvironment comprises not only stromal cells, mainly cancer-associated fibroblasts, but also immune cells of both the innate and adaptive system (tumour-associated macrophages, neutrophils, natural killer cells, and T and B lymphocytes), and endothelial cells. This results in an intricate web of mutual communications regulated by an extensively remodelled extracellular matrix, where the tumour cells are centrally engaged. In this regard, cholangiocarcinoma, in particular the intrahepatic variant, has become the focus of mounting interest in the last years, largely because of the lack of effective therapies despite its rising incidence and high mortality rates worldwide. On the other hand, recent studies in pancreatic cancer, which similarly to cholangiocarcinoma, is highly desmoplastic, have argued against a tumour-promoting function of the tumour microenvironment. In this review, we will discuss recent developments concerning the role of each cellular population and their multifaceted interplay with the malignant biliary epithelial counterpart. We ultimately hope to provide the working knowledge on how their manipulation may lead to a therapeutic gain in cholangiocarcinoma.

Identifiants

pubmed: 30907492
doi: 10.1111/liv.14098
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-78

Subventions

Organisme : NIH HHS
ID : RO1DK-079005-07
Pays : United States
Organisme : NIH HHS
ID : RO1DK096096
Pays : United States

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Luca Fabris (L)

Department of Molecular Medicine, University of Padua, Padova, Italy.
Liver Center and Section of Digestive Diseases, Department of Internal Medicine, Yale University, New Haven, Connecticut.

María J Perugorria (MJ)

Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastián, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.

Joachim Mertens (J)

Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland.

Niklas K Björkström (NK)

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Thorsten Cramer (T)

Department of General, Visceral and Transplantation Surgery, RWTH Aachen University Hospital, Aachen, Germany.
Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
ESCAM - European Surgery Center, Aachen and Maastricht, Germany and The Netherlands.
NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.

Ana Lleo (A)

Division of Internal Medicine and Hepatology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Antonio Solinas (A)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Hanna Sänger (H)

Department of Visceral, Thoracic and Vascular Surgery, University Hospital, Technische Universität Dresden, Dresden, Germany.

Veronika Lukacs-Kornek (V)

Institute of Experimental Immunology, University Hospital, Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Anja Moncsek (A)

Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland.

Alexander Siebenhüner (A)

Department of Hematology and Medical Oncology, University Hospital Zürich, Zürich, Switzerland.

Mario Strazzabosco (M)

Liver Center and Section of Digestive Diseases, Department of Internal Medicine, Yale University, New Haven, Connecticut.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH